| | 圳）有限 | | | 通 | | | --- | --- | --- | --- | --- | --- | | | 公司 | | | 过 核 | | | | | | | 查 | | | | 智驭医疗 | | | 整 改 | | | CQX2500066 | 科技（广 | 颅内血栓抽吸导管 | 珠海市香洲区唐家湾镇科技七路1号珠海中电高科技产业园4栋1-B单元（委托生产），珠 海市高新区唐家湾镇科创东路65号1栋4层（委托生产），珠海市唐家湾镇科技七路1号珠 | 后 通 | 2025/6/20 | | | 州）有限 公司 | | 海中电高科技产业园2栋203单元（委托生产） | 过 | | | | | | | 核 查 | | | | | | | 整 改 | | | | 深圳市辰 纳生物科 | 甲胎蛋白（AFP）测定 | | 后 | | | CSZ2500048 | 技有限公 | 试剂盒（化学发光法） | 深圳市南山区桃源街道塘长路2235号田寮工业A区9栋东座701、708、709 | 通 | 2025/6/23 | | | 司 | | | 过 核 | | | | | | | 查 | | | | | ...

Group 1 - The core business of Kangtai Medical is the research, production, and sales of medical diagnostic and monitoring equipment, covering various categories such as blood oxygen, electrocardiogram, ultrasound, monitoring, and blood pressure [1] - As of the first quarter of 2025, Kangtai Medical reported a revenue of 112 million yuan, representing a year-on-year increase of 12.77%, and a net profit of 16.44 million yuan, with a significant year-on-year increase of 277.67% [1] - The company achieved a gross profit margin of 58.15% in its latest earnings report [1] Group 2 - Kangtai Medical's stock closed at 12.41 yuan, down 1.90%, with a latest price-to-book ratio of 2.70 and a total market capitalization of 4.986 billion yuan [1] - The company has three institutional holders, including two funds and one other entity, with a total holding of 3.3463 million shares valued at 4.6 million yuan [1] - In April 2023, Kangtai Medical's Remoltar remote professional color Doppler ultrasound diagnostic system won the German IF Design Award and the Italian A Design Award [1]